NasdaqCM - Nasdaq Real Time Price USD
ENDRA Life Sciences Inc. (NDRA)
At close: November 15 at 4:00 PM EST
Pre-Market: 4:22 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-9,000.9460
-9,548.7750
-12,769.3710
-11,122.3840
-10,746.5950
Investing Cash Flow
-10.5170
-24.7210
-202.5770
-45.0000
-75.3330
Financing Cash Flow
10,592.7360
7,518.3050
8,399.5120
13,401.6020
11,875.0370
End Cash Position
6,400.7320
2,833.9070
4,889.0980
9,461.5340
7,227.3160
Interest Paid Supplemental Data
61.5320
44.9850
59.1130
57.6550
1.9200
Capital Expenditure
-22.8840
-33.8840
-202.5770
-45.0000
-75.3330
Issuance of Capital Stock
2,919.1130
6,483.3930
8,399.5120
10,615.9750
6,780.9420
Issuance of Debt
--
--
--
--
337.0840
Free Cash Flow
-9,023.8300
-9,582.6590
-12,971.9480
-11,167.3840
-10,821.9280
12/31/2020 - 6/30/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APDN Applied DNA Sciences, Inc.
0.1620
-6.79%
STIM Neuronetics, Inc.
0.7100
-10.13%
MYNZ Mainz Biomed N.V.
0.2387
-4.52%
TTOO T2 Biosystems, Inc.
0.4970
-4.42%
ISPC iSpecimen Inc.
4.2000
-3.45%
CHEK Check-Cap Ltd.
0.7745
-5.55%
PRPH ProPhase Labs, Inc.
0.7500
-0.19%
ACRS Aclaris Therapeutics, Inc.
2.0500
-5.96%
PSNL Personalis, Inc.
3.8900
-9.53%
NOTV Inotiv, Inc.
2.6800
-1.83%